

A successful delivery platform could deliver curative gene‑therapy for PKD and other hereditary kidney disorders, reducing the need for dialysis and transplants for millions of patients, while demonstrating AI’s potential to accelerate biotech innovation.
Comments
Want to join the conversation?
Loading comments...